Synergy between Cpg- or non-CpG DNA and specific antigen for B cell activation

International Immunology

Volumn 15, Issue 2, 2003, Pages 223-231

  Wang, Yiqiang ^a   Krieg, Arthur M ^a,b,c  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c PFIZER INC   (United States)

Author keywords

B lymphocyte; BCR; CpG motif; Immunostimulation; Oligodeoxynucleotide

Indexed keywords

CD69 ANTIGEN; DNA; EPITOPE; IMMUNOGLOBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYSOZYME; MITOGENIC AGENT; OLIGODEOXYNUCLEOTIDE; PHOSPHODIESTERASE; PHOSPHOROTHIOIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; CPG ISLAND; CROSS LINKING; DNA METHYLATION; IMMUNIZATION; IMMUNOREGULATION; IMMUNOSTIMULATION; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL;

ANIMALS; B-LYMPHOCYTES; CELL DIVISION; CPG ISLANDS; DNA; MICE; MICE, INBRED C57BL; MURAMIDASE;

EID: 0037330592     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxg020     Document Type: Article

References (59)

1. Tokunaga, T., Yamamoto, H., Shimada, S., Abe, H., Fukuda, T., Fujisawa, Y., Furutani, Y., Yano, O., Kataoka, T. and Sudo, T. 1984. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J. Natl Cancer Inst. 72:955.
2. Krieg, A. M., Yi, A. K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A. and Klinman, D. M. 1995. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546.
3. Wagner, H. 1999. Bacterial CpG DNA activates immune cells to signal infectious danger. Adv. Immunol. 73:329.
4. Krieg, A. M. 2002. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20:709.
5. h1 immunity and modulates antigen-presenting cell function. Curr. Top. Microbiol. Immunol. 247:199.
6. Zhu, F. G. and Marshall, J. S. 2001. CpG-containing oligodeoxynucleotides induce TNF-alpha and IL-6 production but not degranulation from murine bone marrow-derived mast cells. J. Leukoc. Biol. 69:253.
7. Stan, A. C., Casares, S., Brumeanu, T. D., Klinman, D. M. and Bona, C. A. 2001. CpG motifs of DNA vaccines induce the expression of chemokines and MHC class II molecules on myocytes. Eur. J. Immunol. 31:301.
8. Weighardt, H., Feterowski, C., Veit, M., Rump, M., Wagner, H. and Holzmann, B. 2000. Increased resistance against acute polymicrobial sepsis in mice challenged with immunostimulatory CpG oligodeoxynucleotides is related to an enhanced innate effector cell response. J. Immunol. 165:4537.
9. Schluesener, H. J., Seld, K., Deininger, M. and Schwab, J. 2001. Transient in vivo activation of rat brain macrophages/microglial cells and astrocytes by immunostimulatory multiple CpG oligonucleotides. J. Neuroimmunol. 113:89.
10. h1 responses in lethal murine leishmaniasis. J. Immunol. 160:3627.
11. Walker, P. S., Scharton-Kersten, T., Krieg, A. M., Love-Homan, L., Rowton, E. D., Udey, M. C. and Vogel, J. C. 1999. Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms. Proc. Natl Acad. Sci. USA 96:6970.
12. Elkins, K. L., Rhinehart-Jones, T. R., Stibitz, S., Conover, J. S. and Klinman, D. M. 1999. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J. Immunol. 162:2291.
13. Krieg, A. M., Love-Homan, L., Yi, A. K. and Harty, J. T. 1998. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J. Immunol. 161:2428.
14. h1-promoting adjuvant in immunization against Trypanosoma cruzi. Vaccine 19:234.
15. Cafaro, A., Titti, F., Fracasso, C., Maggiorella, M. T., Baroncelli, S., Caputo, A., Goletti, D., Borsetti, A., Pace, M., Fanales-Belasio, E., Ridolfi, B., Negri, D. R., Sernicola, L., Belli, R., Corrias, F,, Macchia, I., Leone, P., Michelini, Z., ten Haaft, P., Butto, S., Verani, P. and Ensoli, B. 2001. Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89. 6P). Vaccine 19:2862.
16. Deml, L., Schirmbeck, R., Reimann, J., Wolf, H. and Wagner, R. 1999. Immunostimulatory CpG motifs trigger a T helper-1 immune response to human immunodeficiency virus type-1 (HIV-1) gp 160 envelope proteins. Clin. Chem. Lab. Med. 37:199.
17. Moss, R. B., Diveley, J., Jensen, F. C., Gouveia, E. and Carlo, D. J. 2001. Human immunodeficiency virus (HIV)-specific immune responses are generated with the simultaneous vaccination of a gp120-depleted, whole- killed HIV-1 immunogen with cytosine-phosphorothioate-guanine dinucleotide immunostimulatory sequences of DNA. J. Hum. Virol. 4:39.
18. h2-mediated schistosome egg-induced pathology by an IL-12-independent mechanism. J. Immunol. 164:973.
19. Broide, D., Schwarze, J., Tighe, H., Gifford, T., Nguyen, M. D., Malek, S., Van Uden, J., Martin-Orozco, E., Gelfand, E. W. and Raz, E. 1998. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J. Immunol. 161:7054.
20. Sur, S., Wild, J. S., Choudhury, B. K., Sur, N., Alam, R. and Klinman, D. M. 1999. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J. Immunol. 162:6284.
21. Kline, J. N., Waldschmidt, T. J., Businga, T. R., Lemish, J. E., Weinstock, J. V., Thorne, P. S. and Krieg, A. M. 1998. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J. Immunol. 160:2555.
22. h2 balance in asthma. Curr. Top. Microbiol. Immunol. 247:211.
23. Weiner, G. J., Liu, H. M., Wooldridge, J. E., Dahle, C. E. and Krieg, A. M. 1997. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc. Natl Acad. Sci. USA 94:10833.
24. Liu, H. M., Newbrough, S. E., Bhatia, S. K., Dahle, C. E., Krieg, A. M. and Weiner, G. J. 1998. Immunostimulatory CpG oligodeoxynucleotides enhance the immune response to vaccine strategies involving granulocyte-macrophage colony-stimulating factor. Blood 92:3730.
25. Davila, E. and Celis, E. 2000. Repeated administration of cytosine-phosphorothiolated guanine-containing oligonucleotides together with peptide/protein immunization results in enhanced CTL responses with anti-tumor activity. J. Immunol. 165:539.
26. Weiner, G. J. 2001. CpG DNA in cancer immunotherapy. Curr. Top. Microbiol. Immunol. 247:157.
27. Carpentier, A. F., Xie, J., Mokhtari, K. and Delattre, J. Y. 2000. Successful treatment of intracranial gliomas in rat by oligodeoxynucleotides containing CpG motifs. Clin. Cancer Res. 6:2469.
28. Carpentier, A. F., Chen, L., Maltonti, F. and Delattre, J. Y. 1999. Oligodeoxynucleotides containing CpG motifs can induce rejection of a neuroblastoma in mice. Cancer Res. 59:5429.
29. Lanuti, M., Rudginsky, S., Force, S. D., Lambright, E. S., Siders, W. M., Chang, M. Y., Amin, K. M., Kaiser, L. R., Scheule, R. K. and Albelda, S. M. 2000. Cationic lipid:bacterial DNA complexes elicit adaptive cellular immunity in murine intraperitoneal tumor models. Cancer Res. 60:2955.
30. Wooldridge, J. E., Ballas, Z., Krieg, A. M. and Weiner, G. J. 1997. Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma. Blood 89:2994.
31. Decker, T., Schneller, F., Kronschnabl, M., Dechow, T., Lipford, G. B., Wagner, H. and Peschel, C. 2000. Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLI cells: costimulation with IL-2 results in a highly immunogenic phenotype. Exp. Hematol. 28:558.
32. Decker, T., Schneller, F., Sparwasser, T., Tretter, T., Lipford, G. B., Wagner, H. and Peschel, C. 2000. Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells. Blood 95:999.
33. Jahrsdorfer, B., Hartmann, G., Racila, E., Jackson, W., Muhlenhoff, L., Meinhardt, G., Endres, S., Link, B. K., Krieg, A. M. and Weiner, G. J. 2001. CpG DNA increases primary malignant B cell expression of costimulatory molecules and target antigens. J. Leukoc. Biol. 69:81.
34. Krieg, A. M. 1999. A possible cause of joint destruction in septic arthritis. Arthritis Res. 1:3.
35. Deng, G. M., Nilsson, I. M., Verdrengh, M., Collins, L. V. and Tarkowski, A. 1999. Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat. Med. 5:702.
36. Miyata, M., Kobayashi, H., Sasajima, T., Sato, Y. and Kasukawa, R. 2000. Unmethylated oligo-DNA containing CpG motifs aggravates collagen- induced arthritis in mice. Arthritis Rheum. 43:2578.
37. Cowdery, J. S., Chace, J. H., Yi, A. K. and Krieg, A. M. 1996. Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides. J. Immunol. 156:4570.
38. Krieg, A. M. and Davis, H. L. 2001. Enhancing vaccines with immune stimulatory CpG DNA. Curr. Opin. Mol. Ther. 3:15.
39. Klinman, D. M., Yamshchikov, G. and Ishigatsubo, Y. 1997. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol. 158:3635.
40. Sato, Y., Roman, M., Tighe, H., Lee, D., Corr, M., Nguyen, M. D., Silverman, G. J., Lotz, M., Carson, D. A. and Raz, E. 1996. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273:352.
41. Zhao, H., Cheng, S. H. and Yew, N. S. 2000. Requirements for effective inhibition of immunostimulatory CpG motifs by neutralizing motifs. Antisense Nucleic Acid Drug Dev. 10:381.
42. Yew, N. S., Zhao, H., Wu, I. H., Song, A., Tousignant, J. D., Przybylska, M. and Cheng, S. H. 2000. Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. Mol. Ther. 1:255.
43. Tan, Y., Li, S., Pitt, B. R. and Huang, L. 1999. The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo. Hum. Gene Ther. 10:2153.
44. Wagner, H., Lipford, G. B. and Hacker, H. 2000. The role of immunostimulatory CpG-DNA in septic shock. Semin. Immunopathol. 22:167.
45. Sparwasser, T., Miethke, T., Lipford, G., Borschert, K., Hacker, H., Heeg, K. and Wagner, H. 1997. Bacterial DNA causes septic shock. Nature 386:336.
46. Goeckeritz, B. E., Flora, M., Witherspoon, K., Vos, Q., Lees, A., Dennis, G. J., Pisetsky, D. S., Klinman, D. M., Snapper, C. M. and Mond, J. J. 1999. Multivalent cross-linking of membrane Ig sensitizes murine B cells to a broader spectrum of CpG-containing oligodeoxynucleotide motifs, including their methylated counterparts, for stimulation of proliferation and Ig secretion. Int. Immunol. 11:1693.
47. Goodnow, C. C., Crosbie, J., Adelstein, S., Lavoie, T. B., Smith-Gill, S. J., Brink, R. A., Pritchard-Briscoe, H., Wotherspoon, J. S., Loblay, R. H., Raphael, K., Trent, R. J. and Basten, A.. 1988. Altered immunoglobulin expression and functional silencing of self- reactive B lymphocytes in transgenic mice. Nature 334:676.
48. Kilshaw, P. J., McEwan, F. J., Baker, K. C. and Cant, A. J. 1986. Studies on the specificity of antibodies to ovalbumin in normal human serum: technical considerations in the use of ELISA methods. Clin. Exp. Immunol. 66:481.
49. 2+ response amplitude and duration. Nature 386:855.
50. Yi, A. K. and Krieg, A. M. 1998. CpG DNA rescue from anti-IgM-induced WEHI-231 B lymphoma apoptosis via modulation of I kappa B alpha and I kappa B beta and sustained activation of nuclear factor-kappa B/c-Rel. J. Immunol. 160:1240.
51. Krieg, A. M., Hartmann, G. and Yi, A. K. 2000. Mechanism of action of CpG DNA. Curr. Top. Microbiol. Immunol. 247:1.
52. Liang, H., Reich, C. F., Pisetsky, D. S. and Lipsky, P. E. 2000. The role of cell surface receptors in the activation of human B cells by phosphorothioate oligonucleotides. J. Immunol. 165:1438.
53. Boggs, R. T., McGraw, K., Condon, T., Flournoy, S., Villiet, P., Bennett, C. F. and Monia, B. P. 1997. Characterization and modulation of immune stimulation by modified oligonucleotides. Antisense Nucleic Acid Drug Dev. 7:461.
54. McCluskie, M. J. and Davis, H. L. 2000. Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants. Vaccine 19:413.
55. Larsson, M., Fonteneau, J. F. and Bhardwaj, N. 2001. Dendritic cells resurrect antigens from dead cells. Trends Immunol. 22:141.
56. Ishii, K. J., Suzuki, K., Coban, C., Takeshita, F., Itoh, Y., Matoba, H., Kohn, L. D. and Klinman, D. M. 2001. Genomic DNA released by dying cells induces the maturation of APCs. J. Immunol. 167:2602.
57. Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K. and Akira, S. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740.
58. Bauer, S., Kirschning, C. J., Hacker, H., Redecke, V., Hausmann, S., Akira, S., Wagner, H. and Lipford, G. B. 2001. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl Acad. Sci. USA 98:9237.
59. Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchilk, M. J. and Marshak-Rothstein, A. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603.